Skip to main content

RAPT Therapeutics, Inc.

RAPTDelisted Mar 3, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001673772

RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding RAPT Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of RAPT: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders8598+13
Shares29.7M30.0M+249.4K (+0.8%)
Value$542.7M$721.0M+$178.3M (+32.9%)

New holders (22)

Institutions that held RAPT Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Sold out (9)

Institutions that held RAPT Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of RAPT in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
HealthCor Management, L.P.217,165$3.96M
Walleye Capital LLC38,320$699.0K
Man Group plc–$374.0K
Ergoteles LLC12,600$230.0K
Two Sigma Investments, LP11,800$215.0K
Trustees of the University of Pennsylvania10,031$183.0K
Quantbot Technologies LP5,870$107.0K
Group One Trading, L.P.232$4.00K
Northwestern Mutual Wealth Management Co12$0